secwatch.observer — SEC 8-K summary
======================================

Issuer:     TransMedics Group, Inc. (TMDX)
CIK:        0001756262
Form:       8-K
Filed at:   2022-11-04T23:59:59+00:00
Accession:  0001193125-22-277952
Event type: other
Sentiment:  neutral
Materiality: 0.25
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TransMedics amends bylaws to incorporate SEC universal proxy rule requirements
------------------------------------------------------------------------------

- Board approved Second Amended and Restated Bylaws, effective November 2, 2022.
- Amends director nomination procedures to require compliance with SEC Rule 14a-19 (universal proxy).
- Shareholders must disclose proxy solicitation intent and notify company if they fail to comply with Rule.
- No successor, substitute, or replacement nominees allowed after the nomination deadline.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1756262/000119312522277952/0001193125-22-277952-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1756262/000119312522277952/d401238d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-277952

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer